Trial intelligence / Profile preview

Ziprasidone vs Standard Therapy for Acute Agitation in ED

NCT00786318Phase 4Withdrawn

Sponsor
George Washington University
Start
Sep 2008
Primary completion
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ziprasidone in psychomotor agitation, sponsored by George Washington University. Planned start Sep 2008; status: withdrawn.

02

Drugs

ziprasidone
03

Conditions

psychomotor agitation

Beyond the preview

Go deeper on NCT00786318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00786318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call